U.S. medical cannabis enrollments quadrupled from 2016 to 2020
According to a study published in Annals of Internal Medicine, a growing number of people in the United States are participating in medical marijuana programs, with the total exceeding 2.97 million by 2020, more than quadrupling the number of people registered in 2016. Participants in these programs are able to purchase marijuana for medical purposes. Despite the fact that marijuana remains illegal under the federal Controlled Substances Act, the National Conference of State Legislatures says that as of February, 37 states, the District of Columbia, and four US territories had approved it for medical use. State rules vary on which health conditions qualify someone for participation, but the study's researchers discovered that chronic pain (reported by roughly 61 percent of enrollees) is the most prevalent ailment cited by current participants, followed by post-traumatic stress disorder (11 percent). Multiple sclerosis, Alzheimer's, AIDS, glaucoma, Crohn's disease, and chemo